3
views
0
recommends
+1 Recommend
3 collections
    0
    shares
      Are you tired of sifting through news that doesn't interest you?
      Personalize your Karger newsletter today and get only the news that matters to you!

      Sign up

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Sudden Rise of Patients with Acute Macular Neuroretinopathy during the COVID-19 Pandemic

      case-report
      a , b , b
      Case Reports in Ophthalmology
      S. Karger AG
      COVID-19, Vaccine, Acute macular neuroretinopathy

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The aim of this paper is to inform on the surge of cases of acute macular neuroretinopathy (AMN) – a rare disease characterized by the sudden onset of acute scotomas caused by ischemia of the retinal capillary plexus – during the COVID-19 pandemic. In 2021, during the COVID-19 pandemic, a sudden rise in patients with AMN was observed in our clinic. In this paper, 4 cases from a hospital in the south of the Netherlands are reported, all of which could directly be linked to a COVID-19 infection or vaccination against the corona virus. A search for similar cases in the PubMed database produced thirteen relevant reports, which revealed that a similar increase in cases of AMN, all linked to COVID-19, has been observed worldwide. Analysis of the literature revealed that AMN is seen more often during the pandemic and that AMN after COVID-19 happens at a significantly older age than typically reported. This is the largest case series of patients with AMN after COVID-19 infection or vaccination. With the ongoing pandemic and extensive vaccination programs, it is expected that cases of AMN will surge. It is important for ophthalmologists to be aware of this disease, especially since typical patient characteristics may differ.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection

          To the Editor: Ophthalmic complications of COVID-19 are predicted based on prior knowledge of other coronaviruses [1]. Conjunctivitis can be the presenting sign/symptom and its presence correlates with severity [2–4]. Cotton wool spots and retinal microhaemorrhages have also been reported [5]. We report two patients who presented with a new paracentral scotoma following SARS-CoV-2 infection. Patient 1: A 37-year-old Caucasian female in week 14 of an uncomplicated pregnancy presented with a 1-day history of abrupt onset, faintly colourful, left eye paracentral scotoma. This was 35 days following the onset of a febrile illness with cough and anosmia. SARS-CoV-2 nasopharyngeal swab was not performed during the infection, but subsequently positive serology (IgG) has been confirmed. Past medical history included acephalgic visual migraine aura and right toxoplasma chorioretinitis. Examination showed normal visual acuity, no uveitis and fundoscopy was normal in the left eye. OCT changes correlated with the location of the scotoma (Fig. 1). A focal area of hyper-reflective change in the inner and outer plexiform layers with inner nuclear layer volume loss was seen consistent with paracentral acute middle maculopathy (PAMM). Bloods were normal, including ESR, CRP, lipids, glucose, ANA and anti-phospholipid antibodies. An electrocardiogram and carotid Doppler ultrasound were normal. Fig. 1 Optical coherence tomography image from patient 1. Focal area of hyper-reflective change in the inner and outer plexiform layers with inner nuclear layer volume loss consistent with paracentral acute middle maculopathy. Patient 2: A 32-year-old Caucasian male presented with a 4-day history of abrupt onset, faintly colourful, right eye paracentral scotoma. This was 16 days following the onset of nasopharyngeal swab confirmed COVID-19. Past medical history included acephalgic visual migraine aura. Examination showed normal visual acuity, no uveitis and fundoscopy was normal. Changes on infrared reflectance (white arrow) and OCT correlated with the location of the scotoma (Fig. 2). A focal area of faint outer plexiform layer hyper-reflective change (black arrow) and disruption of the interdigitation zone (white box) were seen consistent with acute macular neuroretinopathy (AMN). Fig. 2 Infrared reflectance and optical coherence tomography images from patient 2. Focal area of IR change (white arrow) due to faint outer plexiform layer hyper-reflective change (black arrow) and disruption of the interdigitation zone (white box) on OCT consistent with acute macular neuroretinopathy. These patients developed PAMM and AMN soon after confirmed SARS-CoV-2 infection and possibly represent postinfectious complications. COVID-19 has been reported in association with acute limb ischaemia, stroke and the so called “paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection” [6–8]. PAMM and AMN have similar underlying pathophysiology. PAMM was first described as a variant of AMN [9], but they are now regarded as distinct conditions with overlapping features. PAMM OCT changes are seen in various retinal vascular diseases, such as retinal vein and artery occlusion. OCT angiography (OCT-A) has provided further support for a retinal vascular aetiology in PAMM and AMN [10–15]. Projection resolved OCT-A distinguishes the intermediate from the deep capillary plexus, which run either side of the inner nuclear layer. Using this technique, it has been shown that PAMM occurs in association with reduced flow in the intermediate, deep and occasionally the superficial capillary plexuses, whereas AMN occurs in association with reduced flow in the deep capillary plexus [15]. Finally, in a series of 101 AMN cases, an associated infection or febrile illness was reported in 47.5% [16]. This is the first report of PAMM/AMN following COVID-19. A larger case series is needed to determine if there is a true association.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Acute macular neuroretinopathy following COVID-19 vaccination

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Acute macular neuroretinopathy associated with influenza vaccination with decreased flow at the deep capillary plexus on OCT angiography

              Purpose We report a case of acute macular neuroretinopathy (AMN) following routine annual inactivated influenza vaccination. Projection-resolved optical coherence tomography angiography (PR-OCTA) was used to analyze the retinal capillary flow within the AMN lesion. Observations Our patient reported visual symptoms of her right eye nine days after routine annual influenza vaccination. Multimodal imaging revealed small vessel peripheral vasculitis and AMN in the affected eye. Infectious, immunologic, and hypercoagulable etiologies were investigated and excluded. PR-OCTA B-scans within the AMN lesion demonstrated reduced flow in the deep capillary plexus (DCP) at baseline with relatively improved flow signal in the DCP on follow up, 3 weeks later. Conclusions and importance We report a new association of AMN following routine inactivated influenza immunization. Recent influenza vaccination should be included in the differential diagnosis for patients presenting with AMN. PR-OCTA demonstrated compromised DCP flow in the AMN lesion which has not been previously described.
                Bookmark

                Author and article information

                Journal
                COP
                COP
                10.1159/issn.1663-2699
                Case Reports in Ophthalmology
                S. Karger AG
                1663-2699
                2022
                January – April 2022
                14 February 2022
                : 13
                : 1
                : 96-103
                Affiliations
                [_a] aDepartment of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands
                [_b] bDepartment of Ophthalmology, Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch, The Netherlands
                Article
                522080 PMC8921888 Case Rep Ophthalmol 2022;13:96–103
                10.1159/000522080
                PMC8921888
                35350236
                497cc2d9-a0b8-426e-a2e0-ce6a2437e435
                © 2022 The Author(s). Published by S. Karger AG, Basel

                This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                History
                : 17 December 2021
                : 17 January 2022
                Page count
                Figures: 2, Tables: 2, Pages: 8
                Categories
                Case Report

                Vision sciences,Ophthalmology & Optometry,Pathology
                COVID-19,Acute macular neuroretinopathy,Vaccine

                Comments

                Comment on this article